Condition:1 | Methylene tetrahydrofolate reductase deficiency |
---|---|
SNOMED CT Code:3 | 41797007—5,10-Methylenetetrahydrofolate reductase deficiency UMLS CUI:4C0268615 |
ICD-9-CM Code:5 | 270.4—Disturbances of sulphur-bearing amino-acid metabolism |
ICD-10-CM Code:6 | E72.12—Methylenetetrahydrofolate reductase deficiency |
Deficiency, deficient. methylenetetrahydrofolate reductase E72.12 (MTHFR) Disorder (of) - see also Disease. metabolism NOS E88.9. ICD-10-CM Diagnosis Code E88.9. Metabolic disorder, unspecified. 2016 2017 2018 2019 2020 2021 Billable/Specific Code. amino-acid E72.9. ICD-10-CM Diagnosis Code E72.9.
Methylenetetrahydrofolate reductase deficiency. E72.12 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM E72.12 became effective on October 1, 2018. This is the American ICD-10-CM version of E72.12 - other international versions of ICD-10 E72.12 may differ.
Other primary thrombophilia. D68.59 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM D68.59 became effective on October 1, 2019. This is the American ICD-10-CM version of D68.59 - other international versions of ICD-10 D68.59 may differ.
Genetic susceptibility to other disease. Z15.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM Z15.89 became effective on October 1, 2019.
Some people have a genetic mutation in 1 or both of their MTHFR genes. People with a mutation in 1 MTHFR gene are are said to be heterozygous; if mutations are present in both genes, the person is said to be homozygous or compound heterozygous for the mutation(s).
D68. 51 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D68. 51 became effective on October 1, 2021.
Methylenetetrahydrofolate Reductase (MTHFR) Deficiency is the most common genetic cause of elevated levels of homocysteine in the plasma (hyperhomocysteinemia). The MTHFR enzyme plays an important role in processing amino acids, specifically, the conversion of homocysteine to methionine.
The Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with various diseases (vascular, cancers, neurology, diabetes, psoriasis, etc) with the epidemiology of the polymorphism of the C677T that varies dependent on the geography and ethnicity.
Names and CodesCondition:1Methylene tetrahydrofolate reductase deficiencySNOMED CT Code:341797007—5,10-Methylenetetrahydrofolate reductase deficiency UMLS CUI:4C0268615ICD-9-CM Code:5270.4—Disturbances of sulphur-bearing amino-acid metabolismICD-10-CM Code:6E72.12—Methylenetetrahydrofolate reductase deficiency2 more rows
ICD-10 code Z15. 89 for Genetic susceptibility to other disease is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Not everyone with a mutation has MTHFR gene mutation symptoms. However, because it can impact production of the MTHFR enzyme, it can lead to an MTHFR deficiency, which has the potential to cause problems associated with high levels of homocysteine and low levels of folate and other essential micronutrients.
MTHFR mutations do not require medical treatment. That said, making dietary and lifestyle changes can often help offset any resulting nutritional deficiencies. For example, people with high homocysteine levels due to folate or vitamin B12 deficiencies can take folic acid or vitamin B12, respectively.
Elevated homocysteine levels may cause irritation of the blood vessels and are considered a risk factor for blood clots. Individuals with MTHFR mutations who have normal homocysteine levels are not at increased risk for clots. Thus, the MTHFR mutation by itself is not a clotting disorder.
Heterozygous MTHFR mutations seem to have only minor influences on enzyme activity and health. Heterozygous A1298C is thought to be of minor consequence (if any), while heterozygous C677T may affect folate metabolism by up to 35% (3, 11).
Everyone has two copies of the MTHFR gene, one copy from each parent. If you've been told you have an MTHFR variant, it means you have a difference in either one or both copies of the MTHFR gene. The two most common MTHFR variants are C677T and A1298C.
Two copies of the MTHFR C677T mutation can result in the following symptoms: Decreased enzyme activity levels. Elevated homocysteine levels, especially with concurrent deficiency of vitamins B12, B6 (pyridoxine), or folic acid. 3-fold increased risk for premature cardiovascular disease.
For claims for screening for syphilis in pregnant women at increased risk for STIs use the following ICD-10-CM diagnosis codes: • Z11. 3 - Encounter for screening for infections with a predominantly sexual mode of transmission; • and any of: Z72.
High risk heterosexual behavior51.
Z53. 20 - Procedure and treatment not carried out because of patient's decision for unspecified reasons | ICD-10-CM.
Z53. 09 - Procedure and treatment not carried out because of other contraindication | ICD-10-CM.
Genetic susceptibility to other disease 1 Z15.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM Z15.89 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of Z15.89 - other international versions of ICD-10 Z15.89 may differ.
Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00 -Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
Outlook. Methylenetetrahydrofolate reductase, or MTHFR, is an enzyme that breaks down the amino acid homocysteine. The MTHFR gene that codes for this enzyme has the potential to mutate, which can either interfere with the enzyme’s ability to function normally or completely inactivate it. People have two MTHFR genes, ...
There are two common types, or variants, of MTHFR mutation: C677T and A1298C. Mutations in MTHFR genes occur in approximately 25% of people of Hispanic descent and 10–15% of North American Caucasians.
These mutations in rare occasions lead to high levels of homocysteine in the blood, which may contribute to numerous health conditions, such as: birth abnormalities. glaucoma. mental health disorders. certain types of cancer. In this article, we look at MTHFR mutations in more detail, including related health conditions, diagnosis, ...
Conditions that researchers have associated with MTHFR gene mutations include: homocystinemia, which is the term for abnormally high levels of homocysteine in the blood or urine. ataxia, a neurological condition that affects coordination. peripheral neuropathy, a neurological condition that damages the nerves.
Women who test positive for an MTHFR mutation may have an increased risk of preeclampsia, blood clots, recurrent miscarriages, or giving birth to a baby with congenital disabilities. Multiple studies have been done to determine relationship between the mutation and pregnancy complications, but the data is insufficient in their conclusions.
Having an MTHFR mutation does not affect everyone in the same way. People who have one or more MTHFR variants may have higher-than-normal levels of homocysteine in their blood or urine.
Mutations can occur in one or both genes. Having a parent or close relative with an MTHFR gene mutation can increase a person’s risk of inheriting the same variant. People who have two parents with mutations have an increased risk of having a homozygous MTHFR mutation.